Anthropic expands Claude's use in drug discovery research
Anthropic is getting more involved in drug development with its Claude AI.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Anthropic is getting more involved in drug development with its Claude AI. Its collaborations involving Claude reportedly cover potential treatments for cancer, food allergies and rare muscular disorders. Most of these remain experimental, and Anthropic says the best way to work through bottlenecks is to join real drug programs. Claude Code has reportedly helped scientists shrink cancer therapy components by 70% while boosting cell activity tenfold.
Why it matters
The reports suggest Claude could help scientists find new lifesaving drugs. Most of the projects are still experimental, so no results are confirmed.
Coverage
More from Technology & AI
- China puts humanoid robots to work serving food and sorting parcels
- Newsom proposes sweeping AI safety rules for Washington
- Google releases Gemini 4 Neon AI model with million-token context
- Microsoft and Intel widen their cloud chip partnership
- Google DeepMind rolls out Genie 4 to select subscribers
- AI helped AMD shorten chip design work, OpenAI says